SUPRAMOLECULAR LIPIDIC AGGREGATES (SLAs) AS DELIVERY DEVICES FOR ANTICANCER THERAPY

Research output: Contribution to conferenceOther

Original languageEnglish
Pages41-41
Publication statusPublished - 2007

Cite this